New Parkinson's drug passes first safety check in small trial
Symptom relief
Completed
This early-stage study tested a new drug, HER-096, in 32 people to see if it is safe and how the body processes it. First, healthy volunteers received a single injection. Then, people with Parkinson's disease received multiple injections over four weeks. The main goal was to chec…
Phase: PHASE1 • Sponsor: Herantis Pharma Plc. • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC